DWP14012
Sponsors
Daewoong Pharmaceutical Co. LTD., Konkuk University Medical Center
Conditions
Drug Drug InteractionErosive EsophagitisErosive Gastroesophageal Reflux DiseaseHealthyHealthy Male VolunteersHealthy VolunteersReflux Esophagitis
Phase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers
CompletedNCT02757144
Start: 2016-03-31End: 2017-02-28Target: 120Updated: 2017-04-25
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean
CompletedNCT03574415
Start: 2018-11-01End: 2019-01-23Updated: 2019-06-27
Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs
NCT04490434
Start: 2020-06-19End: 2020-11-30Target: 110Updated: 2020-07-29
Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
CompletedNCT05304845
Start: 2022-03-21End: 2022-05-22Updated: 2023-04-05
Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
CompletedNCT05574374
Start: 2022-09-21End: 2023-03-06Updated: 2023-04-04
Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
NCT05812404
Start: 2022-10-26End: 2023-06-16Target: 36Updated: 2023-04-13